Funder
Bulgarian National Science Fund
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Grinfeld J, Nangalia J, Green AR (2017) Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms. Haematologica 102(1):7
2. Ivanova ID, Pal A, Simonelli I, Atanasova B, Ventriglia M, Rongioletti M et al (2022) Evaluation of zinc, copper, and Cu: Zn ratio in serum, and their implications in the course of COVID-19. J Trace Elem Med Biol 71:126944
3. Malavolta M, Piacenza F, Basso A, Giacconi R, Costarelli L, Mocchegiani E (2015) Serum copper to zinc ratio: relationship with aging and health status. Mech Ageing Dev 151:93–100
4. Stetka J, Usart M, Kubovcakova L, Rai S, Rao TN, Sutter J et al (2023) Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms. Blood J Am Soc Hematol 141(17):2127–2140
5. Loréal O, Cavey T, Bardou-Jacquet E, Guggenbuhl P, Ropert M, Brissot P (2014) Iron, hepcidin, and the metal connection. Front Pharmacol 5:128